🔖
Cite This Article
DOLAİ, T. K., DUTTA, S., MANDAL, P. K., SAHA, S., BHATTACHARYYA, M. (2022). Lenalidomide-Induced Pure Red Cell Aplasia. Turkish Journal of Hematology, Cilt: 31 - Sayı: 1, 99–100. https://ajindex.com/articles/606889
Journals / Turkish Journal of Hematology / 2014 / Cilt: 31 - Sayı: 1
Lenalidomide-Induced Pure Red Cell Aplasia
- Pages
- 99–100
- Publication Date
- 2022-11-05
- DOI
- —
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗References (4)
- Raza A, Reeves JA, Feldman EJ, Dewald GW, Bennett JM, Deeg HJ, Dreisbach L, Schiffer CA, Stone RM, Greenberg PL, Curtin PT, Klimek VM, Shammo JM, Thomas D, Knight RD, Schmidt M, Wride K, Zeldis JB, List AF. Phase 2 study of lenalidomide in transfusion-dependent, low-risk, and intermediate-1–risk myelodysplastic syndromes with karyotypes other than deletion 5q. Blood 2008;111:86-93
- Thompson DF, Gales MA. Drug induced pure red cell aplasia. Pharmacotherapy 1996;16:1002-1008
- Fisch P, Handgretinger R, Schaefer HE. Pure red cell aplasia. Br J Haematol 2000;111:1010-1022
- Ammus SS, Yunis AA. Acquired pure red cell aplasia. Am J Hematol 1987;24:311-326.